GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 743 filers reported holding GLAXOSMITHKLINE PLC in Q2 2016. The put-call ratio across all filers is 0.98 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $20,000 | -4.8% | 550 | 0.0% | 0.01% | -12.5% |
| Q3 2020 | $21,000 | -4.5% | 550 | 0.0% | 0.01% | -11.1% |
| Q2 2020 | $22,000 | +4.8% | 550 | 0.0% | 0.01% | 0.0% |
| Q1 2020 | $21,000 | -19.2% | 550 | 0.0% | 0.01% | -10.0% |
| Q4 2019 | $26,000 | +13.0% | 550 | 0.0% | 0.01% | +11.1% |
| Q3 2019 | $23,000 | +4.5% | 550 | 0.0% | 0.01% | -10.0% |
| Q2 2019 | $22,000 | -4.3% | 550 | 0.0% | 0.01% | 0.0% |
| Q1 2019 | $23,000 | +9.5% | 550 | 0.0% | 0.01% | 0.0% |
| Q4 2018 | $21,000 | -4.5% | 550 | 0.0% | 0.01% | 0.0% |
| Q3 2018 | $22,000 | 0.0% | 550 | 0.0% | 0.01% | -9.1% |
| Q2 2018 | $22,000 | -69.9% | 550 | -70.7% | 0.01% | -70.3% |
| Q1 2018 | $73,000 | +10.6% | 1,874 | 0.0% | 0.04% | -9.8% |
| Q4 2017 | $66,000 | +22.2% | 1,874 | +41.5% | 0.04% | +17.1% |
| Q3 2017 | $54,000 | -25.0% | 1,324 | -20.9% | 0.04% | -30.0% |
| Q2 2017 | $72,000 | +80.0% | 1,674 | +71.7% | 0.05% | +38.9% |
| Q1 2016 | $40,000 | – | 975 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Black Creek Investment Management Inc. | 7,951,626 | $318,224,000 | 10.49% |
| Healthcare Value Capital, LLC | 120,000 | $4,802,000 | 9.01% |
| KAHN BROTHERS GROUP INC | 1,605,014 | $64,232,661,000 | 8.03% |
| Eversept Partners, LP | 693,685 | $28,091,890 | 7.87% |
| EQUITY INVESTMENT CORP | 2,673,764 | $107,004,000 | 3.74% |
| Sio Capital Management, LLC | 379,500 | $15,188,000 | 3.66% |
| Martin Capital Partners, LLC | 115,448 | $4,620,000 | 3.27% |
| Circle Road Advisors LP | 53,028 | $2,122,000 | 3.10% |
| Keystone Financial Planning, Inc. | 156,968 | $6,282,000 | 3.07% |
| CAMG Solamere Management, LLC | 160,294 | $6,415,000 | 2.94% |